Advertisement

Options for When Simple Managements Are Not Enough

  • Roger P. Smith
Chapter

Abstract

Both menstrual pain and heavy menstrual bleeding no longer represent the debilitating threat they once posed. Inexpensive, safe, effective non-prescription therapy available without medical consultation means that dysmenorrhea is no longer the source of disability it once was. When this is not enough, prescription interventions offer exceptional efficacy. When heavy menstrual bleeding is experienced, the placement of a hormone-releasing intrauterine device (LNG-IUS) offers efficacy for 5 or more years with no further actions by the user. Normality can be restored, worry relieved, and function maintained.

Keywords

Reassessment Surgical management Hormonal treatment Combined therapy Decision tree Contraception GnRH agonist Endometriosis Adhesions Hysteroscopy 

References

  1. 1.
    De Sanctis V, Soliman A, Bernasconi S, et al. Primary dysmenorrhea in adolescents: prevalence, impact and recent knowledge. Pediatr Endocrinol Rev. 2015;13(2):512–20.PubMedGoogle Scholar
  2. 2.
    Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281.Google Scholar
  3. 3.
    Lee B, Hong SH, Kim K, et al. Efficacy of the device combining high-frequency transcutaneous electrical nerve stimulation and thermotherapy for relieving primary dysmenorrhea: a randomized, single-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;194:58–63.CrossRefPubMedGoogle Scholar
  4. 4.
    Igwea SE, Tabansi-Ochuogu CS, Abaraogu UO. TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea: a systematic review. Complement Ther Clin Pract. 2016;24:86–91.CrossRefPubMedGoogle Scholar
  5. 5.
    Yiu KW, Chan SS, Chung TK. Mothers’ attitude to the use of a combined oral contraceptive pill by their daughters for menstrual disorders or contraception. Hong Kong Med J. 2017;23(2):150–7.PubMedGoogle Scholar
  6. 6.
    Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D. Adolescents’ experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol. 2005;18(2):85–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Ling FW, For the Pelvic Pain Study Group. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol. 1999;93:51–8.PubMedGoogle Scholar
  8. 8.
    American College of Obstetricians and Gynecologists. Management of endometriosis. Practice Bulletin No. 113. Obstet Gynecol. 2010;116:223–36.CrossRefGoogle Scholar
  9. 9.
    Sulak PJ, Cressman BE, Waldrop E, Holleman S, Kuehl TJ. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol. 1997;89(2):179–83.CrossRefPubMedGoogle Scholar
  10. 10.
    Wilkinson JP, Kadir RA. Management of abnormal uterine bleeding in adolescents. J Pediatr Adolesc Gynecol. 2010;23:S22–30.CrossRefPubMedGoogle Scholar
  11. 11.
    Lichten EM, Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. J Reprod Med. 1987;32:37–41.PubMedGoogle Scholar
  12. 12.
    Vercellini P, Aimi G, Busacca M, et al. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril. 2003;80(2):310–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Proctor ML, Latthe PM, Farquhar CM, et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2005;(4):CD001896.Google Scholar
  14. 14.
    Latthe PM, Proctor ML, Farquhar CM, Johnson N, Khan KS. Surgical interruption of pelvic nerve pathways in dysmenorrhea: a systematic review of effectiveness. Acta Obstet Gynecol Scand. 2007;86(1):4–15.CrossRefPubMedGoogle Scholar
  15. 15.
    Webster JC. Diseases of women: a text-book for students and practitioners. Edinburgh & London: Young J. Pentland; 1898. p. 57. Fig. 29Google Scholar
  16. 16.
    Yen YK, Liu WM, Yuan CC, Ng HT. Addition of laparoscopic uterine nerve ablation to laparoscopic bipolar coagulation of uterine vessels for women with uterine myomas and dysmenorrhea. J Am Assoc Gynecol Laparosc. 2001;8(4):573–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Juang CM, Chou P, Yen MS, et al. Laparoscopic uterosacral nerve ablation with and without presacral neurectomy in the treatment of primary dysmenorrhea: a prospective efficacy analysis. J Reprod Med. 2007;52:591–6.PubMedGoogle Scholar
  18. 18.
    Chen FP, Chang SD, Chu KK, Soong YK. Comparison of laparoscopic presacral neurectomy and laparoscopic uterine nerve ablation for primary dysmenorrhea. J Reprod Med. 1996;41:463–6.PubMedGoogle Scholar
  19. 19.
    Papasakelariou C. Long-term results of laparoscopic uterosacral nerve ablation. Gynaecol Endosc. 1996;5:177–9.Google Scholar
  20. 20.
    Moawad NS, Santamaria E, Johnson M, Shuster J. Cost-effectiveness of office hysteroscopy for abnormal uterine bleeding. JSLS. 2014;18(3.) pii: e2014.00393Google Scholar
  21. 21.
    Di Spiezio SA, Spinelli M, Zizolfi B, Nappi C. Ambulatory management of heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):35–43.CrossRefGoogle Scholar
  22. 22.
    DI Spiezio Sardo A, Ceci O, Zizolfi B, Nappi C, Bettocchi S. Office myomectomy. Minerva Ginecol. 2016;68(3):321–7.PubMedGoogle Scholar
  23. 23.
    Wortman M. “See-and-treat” hysteroscopy in the management of endometrial polyps. Surg Technol Int. 2016;28:177–84.PubMedGoogle Scholar
  24. 24.
    Keyhan S, Munro MG. Office diagnostic and operative hysteroscopy using local anesthesia only: an analysis of patient reported pain and other procedural outcomes. J Minim Invasive Gynecol. 2014;21(5):791–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Cooper NA, Middleton L, Smith P, et al. OPT trial collaborative group. A patient-preference cohort study of office versus inpatient uterine polyp treatment for abnormal uterine bleeding. Gynecol Surg. 2016;13(4):313–22.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Duplay S, Clado S. Traité d'Hystéroscopie, Instrumentation, Technique Opératoire, Études Cliniques. Rennes: Fr. Simon, Succ De A Le Roy, Impriveur Dreveté; 1898. p. 60.Google Scholar
  27. 27.
    Davies J, Kadir RA. Heavy menstrual bleeding: an update on management. Thromb Res. 2017;151(Suppl 1):S70–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Fergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;(11):CD000329.Google Scholar
  29. 29.
    Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2016;(1):CD003855.Google Scholar
  30. 30.
    Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid. 2011;2011. pii: 0814Google Scholar
  31. 31.
    Scarperi S, Pontrelli G, Campana C, et al. Laparoscopic radiofrequency thermal ablation for uterine adenomyosis. JSLS. 2015;19(4.) pii: e2015.00071Google Scholar

Additional Resources

  1. American College of Obstetricians and Gynecologists. Endometrial ablation. ACOG Practice Bulletin No. 81. Obstet Gynecol. 2007;109:1233–48.CrossRefGoogle Scholar
  2. American College of Obstetricians and Gynecologists. Alternatives to hysterectomy in the management of leiomyomas. ACOG Practice Bulletin No. 96. Obstet Gynecol. 2008;112:201–7.CrossRefGoogle Scholar
  3. Centini G, Troia L, Lazzeri L, Petraglia F, Luisi S. Modern operative hysteroscopy. Minerva Ginecol. 2016;68(2):126–32.PubMedGoogle Scholar
  4. Davies J, Kadir RA. Heavy menstrual bleeding: an update on management. Thromb Res. 2017;151(Suppl 1):S70–7.CrossRefPubMedGoogle Scholar
  5. Gimpelson RJ. Office hysteroscopy. Clin Obstet Gynecol. 1992;35(2):270–81.CrossRefPubMedGoogle Scholar
  6. Heikinheimo O, Fraser I. The current status of hormonal therapies for heavy menstrual bleeding. Best Pract Res Clin Obstet Gynaecol. 2017;40:111–20.CrossRefPubMedGoogle Scholar
  7. Kwok A, Lam A, Ford R. Laparoscopic presacral neurectomy: a review. Obstet Gynecol Surv. 2001;56(2):99–104.CrossRefPubMedGoogle Scholar
  8. Kumar V, Chodankar R, Gupta JK. Endometrial ablation for heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):45–52.CrossRefGoogle Scholar
  9. Maybin JA, Critchley HO. Medical management of heavy menstrual bleeding. Womens Health (Lond). 2016;12(1):27–34.CrossRefGoogle Scholar
  10. Ray S, Ray A. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders. Cochrane Database Syst Rev. 2016;(11):CD010338.Google Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Roger P. Smith
    • 1
  1. 1.Florida Atlantic UniversityBoca RatonUSA

Personalised recommendations